pancreas cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
pancreas cancer
Jun 24, 2024, 22:56 |
Blog
Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer
Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…
Jun 7, 2024, 19:48 |
Blog
Ramy Sedhom: The GIANT TRIAL presented by Efrat Dotan at ASCO24
Ramy Sedhom shared on X/Twitter: "Wanted to highlight a key RCT presented by Efrat Dotan at…
May 7, 2024, 10:39 |
Blog
Caryn Lerman: Saul Priceman will be the founding director of the new KSOM/USC Norris Center for Cancer Cellular Immunotherapy Research
Caryn Lerman, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on LinkedIn:…
May 3, 2024, 13:07 |
Blog
Edward Christopher: Memorial Sloan Kettering Cancer Center experience of ablative radiation for local recurrence of pancreas cancer
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology Service at UT Southwestern Medical…
Apr 6, 2024, 15:58 |
Insight
Noelle LoConte: Same People, Different Results
Noelle LoConte, Associate Professor at University of Wisconsin-Madison, recently shared on X: "New publication! 'Same…
Dec 20, 2023, 11:38 |
Blog
Celebrating Journal of Clinical Oncology's 40th
Journal of Clinical Oncology shared a post on X/Twitter: "Celebrating JCO's 40th: Congrats to the…
Nov 15, 2023, 13:19 |
Blog
Sepideh Gholami: Another successful annual pancreas cancer symposium at Northwell Health
Sepideh Gholami, Liver and Pancreas Surgeon-Scientist at Northwell Health and Cold Spring Harbor Laboratory, shared…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube